ARYX (ARYx Therapeutics) YoY EPS Growth: 73.33% (As of Sep. 2010)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ARYx Therapeutics YoY EPS Growth?

ARYx Therapeutics ARYX -99.80% YoY EPS Growth is 73.33% as of Sep. 2010.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. ARYx Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2010 was 73.33%.

ARYx Therapeutics's Earnings per Share (Diluted) for the three months ended in Sep. 2010 was $-0.08.

ARYx Therapeutics YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for ARYx Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYx Therapeutics YoY EPS Growth Chart

ARYx Therapeutics Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
YoY EPS Growth
Get a 7-Day Free Trial -26.57 12.66 69.30 79.98 26.67

ARYx Therapeutics Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -276.47 66.13 38.89 67.65 73.33

ARYx Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

ARYx Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2009 is calculated as:

YoY EPS Growth (A: Dec. 2009 )
=(Earnings per Share (Diluted) (A: Dec. 2009 )-Earnings per Share (Diluted) (A: Dec. 2008 ))/ | Earnings per Share (Diluted) (A: Dec. 2008 ) |
=(-1.21--1.65)/ | -1.65 |
=26.67 %

ARYx Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2010 is calculated as:

YoY EPS Growth (Q: Sep. 2010 )
=(Earnings per Share (Diluted) (Q: Sep. 2010 )-Earnings per Share (Diluted) (Q: Sep. 2009 )) / | Earnings per Share (Diluted) (Q: Sep. 2009 )) |
=(-0.08--0.3)/ | -0.3 |
=73.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 73.33% mean?
ARYx Therapeutics (ARYX) has a YoY EPS Growth of 73.33% as of Sep. 2010. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for ARYx Therapeutics and its competitors.
Is ARYx Therapeutics' YoY EPS Growth too high?
ARYx Therapeutics' current YoY EPS Growth is 73.33%.
How does ARYx Therapeutics' YoY EPS Growth compare to YBAO and HPMM?
ARYx Therapeutics' YoY EPS Growth of 73.33% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Drug Manufacturers company?
A good YoY EPS Growth depends on the Drug Manufacturers industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for ARYx Therapeutics and its competitors. ARYx Therapeutics's current YoY EPS Growth is 73.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARYx Therapeutics stock overvalued right now?
ARYx Therapeutics (ARYX) has a current YoY EPS Growth of 73.33%. The current YoY EPS Growth is 73.33%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For ARYx Therapeutics (ARYX), the current YoY EPS Growth is 73.33% as of Sep. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ARYx Therapeutics Business Description

Address 6300 Dumbarton Circle, Fremont, CA, USA, 94555
ARYx Therapeutics Inc is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs.